Your Best Stock

Pfizer PFE

$28.48
+$0.30 (+1.05%)
Market open · Sep 24, 1:10 pm ET
After hours $28.19 +0.02%
Open$28.20
Prev close$28.18
Day range$28.20 – $28.85
Volume18.08M
Market cap$162.27B
P/E (TTM)37.5
Dividend yield6.04%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$15.03B+2.6% YoY
Operating profit$3.54B-6.1% YoY
Net profit-$237.00M-108.1% YoY
Diluted EPS-$0.04-107.8% YoY
Free cash flow$302.00M+125.2% YoY
Operating cash flow$835.00M

Revenue, last 8 quarters

$17.7BSep '24$17.8BDec '24$13.7BMar '25$14.7BJun '25$16.7BSep '25$17.6BDec '25$14.5BMar '26$15.0BJun '26

Net profit, last 8 quarters

$4.5BSep '24$418.0MDec '24$3.0BMar '25$2.9BJun '25$3.6BSep '25$-1.6BDec '25$2.7BMar '26$-237.0MJun '26

Diluted EPS by quarter

0.78Sep '240.07Dec '240.52Mar '250.51Jun '250.62Sep '25-0.29Dec '250.47Mar '26-0.04Jun '26

Free cash flow by quarter

$6.1BSep '24$5.8BDec '24$1.8BMar '25$-1.2BJun '25$4.0BSep '25$4.5BDec '25$2.2BMar '26$302.0MJun '26

Annual revenue

$41.7BFY20$81.3BFY21$101.2BFY22$59.6BFY23$63.6BFY24$62.6BFY25

Profitability & balance sheet

Gross margin73.2%
Operating margin26.7%
Net margin6.8%
Return on equity5.0%
Return on assets2.1%
Return on invested capital3.8%
Current ratio1.27
Liabilities / assets57.5%
Cash & investments$11.70B
Total debt$63.19B
Net cash (debt)-$51.50B
Free cash flow / sales17.2%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • BioPharma$14.66B 97.5%
  • Other business activities$373.00M 2.5%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $15.03B $14.45B $62.58B $17.56B $16.65B
Total Operating Revenue $15.03B $14.45B $62.58B $17.56B $16.65B
Cost of Revenue $4.09B $3.55B $16.07B $5.27B $4.17B
Gross Profit $10.94B $10.90B $46.51B $12.29B $12.48B
Operating Expense $7.41B $6.63B $29.11B $8.60B $6.96B
Selling and Admin Expenses $3.41B $2.96B $13.79B $4.16B $3.19B
Research & Development $2.81B $2.49B $10.44B $3.21B $2.55B
Depreciation & Amortization & Depletion $1.19B $1.18B $4.87B $1.23B $1.22B
-Depreciation & Amortization $1.19B $1.18B $4.87B $1.23B $1.22B
Operating Profit $3.54B $4.27B $17.41B $3.69B $5.53B
Net Non-Operating Interest Income (Expense) -$554.00M -$553.00M -$2.07B -$545.00M -$514.00M
Non-Operating Interest Income $113.00M $115.00M $603.00M $166.00M $138.00M
Non-Operating Interest Expense $667.00M $668.00M $2.67B $711.00M $652.00M
Other Income (Expense) -$3.64B -$544.00M -$7.82B -$4.79B -$1.68B
Gain on Sale of Security $61.00M -$9.00M $198.00M -$36.00M $201.00M
Special Income (Charges) -$4.03B -$723.00M -$9.16B -$5.34B -$2.13B
-Less:Restructuring and Mergern & Acquisition $712.00M $395.00M $1.55B $604.00M $286.00M
-Less:Impairment of Capital Assets $4.33B $0.00 $4.94B $4.47B $260.00M
-Less:Other Special Charges $858.00M $328.00M $2.67B $514.00M $1.58B
-Gain on Sale Of Business $1.87B
Other Non-Operating Income (Expenses) $329.00M $188.00M $1.14B $588.00M $247.00M
Pretax Profit -$653.00M $3.17B $7.52B -$1.64B $3.33B
Tax -$407.00M $461.00M -$266.00M -$2.00M -$216.00M
Net Profit -$237.00M $2.70B $7.81B -$1.64B $3.55B
Profit from Continuing Operations -$246.00M $2.71B $7.79B -$1.64B $3.55B
Net Income from Discontinuous Operations $8.00M -$13.00M $25.00M $0.00 $0.00
Minority Interests $10.00M $8.00M $41.00M $8.00M $9.00M
Net Income to Parent Company -$248.00M $2.69B $7.77B -$1.65B $3.54B
Net Income to Common Stockholders -$248.00M $2.69B $7.77B -$1.65B $3.54B
Basic EPS -$0.04 $0.47 $1.37 -$0.29 $0.62
Diluted EPS -$0.04 $0.47 $1.36 -$0.29 $0.62
Dividend Per Share $0.43 $0.43 $1.72 $0.43 $0.43
Earnings from Equity Interest $0.00 $0.00 $0.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $201.13B $207.62B $208.16B $208.16B $208.73B
Total Current Assets $41.36B $42.82B $42.90B $42.90B $46.92B
Cash and Cash Equivalents & Short-Term Investments $11.70B $13.08B $13.60B $13.60B $14.98B
-Cash and Cash Equivalents $976.00M $1.70B $1.14B $1.14B $1.34B
-Short Term Investments $10.72B $11.37B $12.45B $12.45B $13.64B
Receivables $16.19B $16.17B $15.84B $15.84B $18.12B
-Accounts Receivable $12.49B $12.59B $11.87B $11.87B $14.26B
-Taxes Receivable $3.70B $3.59B $3.97B $3.97B $3.86B
Inventory $9.95B $10.67B $10.65B $10.65B $11.47B
Other Current Assets $3.52B $2.91B $2.81B $2.81B $2.36B
Total Non-Current Assets $159.77B $164.79B $165.26B $165.26B $161.81B
Net PPE $19.03B $19.40B $19.32B $19.32B $18.88B
-Gross PPE $37.13B $37.21B $36.70B $36.70B $36.39B
-Accumulated Depreciation -$18.10B -$17.80B -$17.39B -$17.39B -$17.51B
Investments and Advances $1.56B $1.63B $1.62B $1.62B $2.14B
-Available for Sale Securities $1.27B $1.34B $1.34B $1.34B $1.87B
-Held to Maturity Securities $49.00M $47.00M $48.00M $48.00M $48.00M
-Long Term Equity Investment $241.00M $237.00M $235.00M $235.00M $223.00M
Goodwill and Other Intangible Assets $118.47B $123.97B $124.99B $124.99B $120.43B
-Goodwill $71.42B $71.41B $71.26B $71.26B $69.10B
-Other Intangible Assets $47.05B $52.56B $53.73B $53.73B $51.32B
Non-Current Deferred Assets $10.77B $9.97B $9.70B $9.70B $11.05B
Other Non-Current Assets $9.94B $9.83B $9.63B $9.63B $9.32B
Total Liabilities $115.64B $117.21B $121.39B $121.39B $115.64B
Total Current Liabilities $32.65B $34.35B $36.98B $36.98B $36.60B
Payables $7.69B $7.64B $10.79B $10.79B $8.82B
-Accounts Payable $4.58B $4.51B $5.24B $5.24B $5.02B
-Total Tax Payable $653.00M $3.13B $3.10B $3.10B $3.80B
-Dividends Payable $2.45B $0.00 $2.45B $2.45B $0.00
Short-Term Debt and Capital Lease Obligation $2.70B $3.89B $3.15B $3.15B $4.30B
-Current Debt $2.70B $3.89B $3.15B $3.15B $4.30B
Other Current Liabilities $19.71B $20.11B $18.65B $18.65B $19.51B
Total Non-Current Liabilities $82.99B $82.87B $84.40B $84.40B $79.04B
Long Term Accounts Payable and Other Payables $3.82B $3.71B $3.59B $3.59B $3.40B
Long Term Debt and Capital Lease Obligation $60.50B $59.84B $60.81B $60.81B $56.55B
-Long Term Debt $60.50B $59.84B $60.81B $60.81B $56.55B
Non-Current Deferred Liabilities $1.96B $2.41B $2.40B $2.40B $2.47B
Employee Benefits $1.94B $1.98B $2.04B $2.04B $2.16B
Other Non-Current Liabilities $14.78B $14.20B $14.73B $14.73B $13.61B
Total Equity $85.49B $90.40B $86.78B $86.78B $93.10B
Stockholders' Equity $85.19B $90.10B $86.48B $86.48B $92.80B
Capital Stock $482.00M $482.00M $481.00M $481.00M $481.00M
-Common Stock $482.00M $482.00M $481.00M $481.00M $481.00M
Additional Paid-In Capital $95.03B $94.77B $94.47B $94.47B $94.25B
Retained Earnings $112.09B $117.24B $114.61B $114.61B $121.15B
Less: Treasury Stock $115.19B $115.19B $115.02B $115.02B $115.01B
Gains/Losses Not Affecting Retained Earnings -$7.22B -$7.20B -$8.07B -$8.07B -$8.07B
Other Equity Interests -$1.00M $1.00M $1.00M
Minority Interests $302.00M $303.00M $299.00M $299.00M $295.00M
Derivative Product Liabilities $726.00M $834.00M $834.00M $864.00M
Current Deferred Liabilities $784.00M $784.00M $924.00M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $835.00M $2.62B $11.70B $5.35B $4.60B
Net cash flow from continuing operations $860.00M $2.59B $11.71B $5.35B $4.60B
Net Income from Continuing Operations -$220.00M $2.68B $7.79B -$1.64B $3.55B
Depreciation & Depletion & Amortization $1.62B $1.61B $6.59B $1.69B $1.66B
Deferred Tax -$1.32B -$12.00M -$2.13B -$433.00M -$765.00M
Other Non-Cash Items -$203.00M -$241.00M -$1.26B -$487.00M -$376.00M
Change in Working Capital -$1.82B -$1.73B -$5.35B $1.59B -$36.00M
Net cash flow from investing $2.11B $785.00M -$1.35B -$6.15B -$2.43B
Net Cash Flow from Continuing Investing Activities $2.11B $785.00M -$1.35B -$6.15B -$2.43B
Net PPE Purchase and Sale -$533.00M -$436.00M -$2.63B -$845.00M -$602.00M
Net Business Purchase and Sale $0.00 $0.00 -$616.00M -$6.93B $0.00
Net Investment Purchase and Sale $2.64B $1.20B $1.73B $1.76B -$1.84B
Net Other Investing Changes -$1.00M $22.00M $165.00M -$137.00M $12.00M
Financing Cash Flow -$3.66B -$2.86B -$10.30B $596.00M -$2.48B
Net Cash Flow from Continuing Financing Activities -$3.66B -$2.86B -$10.30B $597.00M -$2.48B
Net Issuance Payments Of Debt -$1.19B -$127.00M -$74.00M $3.09B $6.00M
Cash Dividends Paid -$2.45B -$2.45B -$9.77B -$2.45B -$2.44B
Net Other Financing Charges -$26.00M -$284.00M -$459.00M -$44.00M -$39.00M
Ending Cash Balance $1.03B $1.76B $1.20B $1.20B $1.39B
Net Change in Cash -$722.00M $544.00M $49.00M -$202.00M -$302.00M
Beginning Cash Balance $1.76B $1.20B $1.11B $1.39B $1.69B
Effect of Exchange Rate Changes -$4.00M $19.00M $41.00M $5.00M $2.00M
Free Cash Flow $302.00M $2.18B $9.08B $4.50B $4.00B
-Change in Receivables -$263.00M
-Change in Inventory $561.00M
-Change in Payables and Accrued Expense -$469.00M
-Change in Other Current Assets $1.29B
-Change in Other Current Liabilities -$3.67B
-Change In Other Working Capital -$2.81B
Scroll to Top